(Q79078399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists (English)

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

13 March 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

13 March 2024

author name string

Marlys Hammond

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Richard L. Elliott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Robert M. Oliver

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Janet A. LaFlamme

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Melissa L. Gillaspy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Richard F. Hank

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Tristan S. Maurer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Demetria L. Baker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Paul A. DaSilva-Jardine

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Ralph W. Stevenson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

Christine M. Mack

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

James V. Cassella

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505677

13 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14505677

13 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

20 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14505677

full work available at URL

13 March 2024

https://api.elsevier.com/content/article/PII:S0960894X03007479?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

https://api.elsevier.com/content/article/PII:S0960894X03007479?httpAccept=text/plain

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00747-9

Bioorganic & Medicinal Chemistry Letters

13 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

3593-3596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

A receptor subtype involved in neuropeptide-Y-induced food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900747-9

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14505677%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference